Tri-City Cervical Cancer Prevention Study Among Women in the Justice System
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 3R01CA226838-02S1
Grant search
Key facts
Disease
COVID-19Start & end year
20202023Known Financial Commitments (USD)
$88,651Funder
National Institutes of Health (NIH)Principal Investigator
Megha RamaswamyResearch Location
United States of AmericaLead Research Institution
University Of Kansas Medical CenterResearch Priority Alignment
N/A
Research Category
Research to inform ethical issues
Research Subcategory
Research to inform ethical issues related to Social Determinants of Health, Trust, and Inequities
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Minority communities unspecified
Occupations of Interest
Unspecified
Abstract
Abstract: In response to NOT-OD-20-097, we propose to conduct supplemental research to examine the impact of the COVID-19 outbreak on cancer-related health care service utilization, health beliefs, and health disparities in an ongoing study of medically and socially vulnerable women. The parent study, Tri-City Cervical Cancer Prevention Study among Women in the Justice System (# R01CA226838) is a natural history study of cervical cancer risk among women involved in the criminal justice (CJ) system in Kansas City, KS, Birmingham, AL and Oakland, CA (N=497). We will leverage this ongoing longitudinal study to address the following Aims: 1) To examine how the COVID-19 outbreak affects cancer and other health screening and care among women at elevated risk for cervical cancer; 2) To understand how the COVID-19 outbreak and related public health mandates contribute to health disparities among women at high risk for cervical cancer. The proposed research will provide critical information about how pandemics contribute to disparities in cancer and health among poor women and women of color. Knowledge gained from this supplemental research will translate to better patient, provider, and systems-level interventions that are equipped to handle pandemics and thecancer, health, and social needs of poor women.